Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-029971
Filing Date
2024-12-20
Accepted
2024-12-20 16:15:09
Documents
1
Period of Report
2024-12-19

Document Format Files

Seq Description Document Type Size
1 form4-12202024_041206.html 4  
1 form4-12202024_041206.xml 4 13691
  Complete submission text file 0001415889-24-029971.txt   15111
Mailing Address 45 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 45 SIDNEY STREET CAMBRIDGE MA 02139 617-374-7580
Blueprint Medicines Corp (Issuer) CIK: 0001597264 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address BLUEPRINT MEDICINES CORP. 215 FIRST STREET, SUITE 340/350 CAMBRIDGE MA 02142
Business Address
Albers Jeffrey W. (Reporting) CIK: 0001638474 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37359 | Film No.: 241568130